SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director and CEO, Stephen Carter presents on the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa at FNN's Investor Event.
- World leader in reformulating and delivering medication through oral spray
- Has increased bioavailability up to 95 per cent
- This is a major step forward in the evolution of drug delivery technology
- Faster, potentially smaller doses & safer delivery for ex-blockbuster drugs
- Technology validated with licensing deals with Teva and Mitsubishi
- Robust intellectual property portfolio with over 50 patents
For more, watch Managing Director and CEO Stephen Carter present.